Lam Research Corporation $LRCX Shares Sold by Metis Global Partners LLC

Metis Global Partners LLC trimmed its position in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 13.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 56,923 shares of the semiconductor company’s stock after selling 8,768 shares during the period. Metis Global Partners LLC’s holdings in Lam Research were worth $5,541,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in LRCX. Penserra Capital Management LLC increased its position in shares of Lam Research by 2.3% in the 2nd quarter. Penserra Capital Management LLC now owns 250,963 shares of the semiconductor company’s stock valued at $24,427,000 after purchasing an additional 5,713 shares during the last quarter. Wedbush Securities Inc. increased its holdings in Lam Research by 19.5% in the second quarter. Wedbush Securities Inc. now owns 20,968 shares of the semiconductor company’s stock valued at $2,041,000 after buying an additional 3,425 shares during the last quarter. Vestmark Advisory Solutions Inc. acquired a new stake in Lam Research in the second quarter valued at $483,000. Walkner Condon Financial Advisors LLC purchased a new stake in Lam Research during the 2nd quarter worth about $222,000. Finally, Smart Money Group LLC acquired a new position in shares of Lam Research during the 2nd quarter worth about $280,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Analysts Set New Price Targets

LRCX has been the topic of several research analyst reports. Dbs Bank raised their target price on Lam Research from $119.40 to $184.20 in a research report on Monday, October 27th. Oppenheimer set a $200.00 price objective on shares of Lam Research and gave the stock an “outperform” rating in a report on Thursday, October 23rd. Barclays set a $142.00 price objective on shares of Lam Research and gave the stock an “equal weight” rating in a research report on Monday, October 20th. Evercore ISI increased their target price on shares of Lam Research from $115.00 to $170.00 and gave the company an “outperform” rating in a research report on Thursday, October 23rd. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $148.54.

Read Our Latest Analysis on Lam Research

Lam Research Stock Down 1.8%

Shares of NASDAQ:LRCX opened at $159.35 on Friday. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $166.92. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. The stock has a market cap of $200.15 billion, a P/E ratio of 35.10, a P/E/G ratio of 1.68 and a beta of 1.87. The firm has a fifty day moving average price of $134.94 and a 200 day moving average price of $106.61.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same period in the previous year, the business posted $0.86 earnings per share. Lam Research’s quarterly revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Sell-side analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is presently 22.91%.

Insider Buying and Selling at Lam Research

In related news, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares in the company, valued at $34,870,428.30. This trade represents a 17.21% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Bethany Mayer sold 1,298 shares of the business’s stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the transaction, the director directly owned 1,652 shares in the company, valued at $264,303.48. This represents a 44.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 62,498 shares of company stock worth $8,875,663. 0.31% of the stock is currently owned by insiders.

Lam Research Company Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Featured Stories

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.